(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health...
Stats | |
---|---|
आज की मात्रा | 172 513 |
औसत मात्रा | 110 098 |
बाजार मूल्य | 1.87B |
EPS | $-0.120 ( 2023-11-08 ) |
अगली कमाई की तारीख | ( $-0.100 ) 2024-06-10 |
Last Dividend | $0.0722 ( 2019-01-11 ) |
Next Dividend | $0 ( N/A ) |
P/E | -21.08 |
ATR14 | $0.00700 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2018-10-22 | Anderson Mark Monroe | Buy | 100 000 | Stock Option (right to buy) |
2018-10-22 | Anderson Mark Monroe | Buy | 0 | |
2018-08-13 | Smith Scott Clifford | Buy | 100 000 | Stock Option (right to buy) |
2018-08-13 | Smith Scott Clifford | Buy | 0 | |
2018-08-13 | Laffer Arthur B | Buy | 100 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 13 transactions |
Buy: 500 392 | Sell: 1 057 |
मात्रा सहसंबंध
Eaton Vance Ohio सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
SOJD | 0.872 |
RYB | 0.869 |
WPM | 0.869 |
NEU | 0.869 |
KBH | 0.867 |
SAP | 0.851 |
GLDM | 0.85 |
SGOL | 0.85 |
OUNZ | 0.849 |
BAR | 0.849 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
DZZ | -0.856 |
EQNR | -0.84 |
GLL | -0.836 |
DGZ | -0.835 |
EBF | -0.829 |
DBMF | -0.817 |
RPM | -0.814 |
PKO | -0.814 |
PCQ | -0.814 |
KMLM | -0.809 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Eaton Vance Ohio सहसंबंध - मुद्रा/वस्त्र
Eaton Vance Ohio वित्तीय
Annual | 2023 |
राजस्व: | $781.43M |
सकल लाभ: | $175.05M (22.40 %) |
EPS: | $-0.470 |
FY | 2023 |
राजस्व: | $781.43M |
सकल लाभ: | $175.05M (22.40 %) |
EPS: | $-0.470 |
FY | 2022 |
राजस्व: | $751.45M |
सकल लाभ: | $174.07M (23.16 %) |
EPS: | $-0.990 |
FY | 2021 |
राजस्व: | $618.03M |
सकल लाभ: | $151.54M (24.52 %) |
EPS: | $0.650 |
Financial Reports:
No articles found.
Eaton Vance Ohio Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0561 | 2001-01-05 |
Last Dividend | $0.0722 | 2019-01-11 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 221 | -- |
Total Paid Out | $14.33 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.4 | -- |
Div. Sustainability Score | 3.29 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 1.328 | -- |
Year | Amount | Yield |
---|---|---|
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $1.008 | 24.50% |
2005 | $1.024 | 55.70% |
2006 | $0.704 | 34.50% |
2007 | $0.650 | 153.20% |
2008 | $0.738 | 177.80% |
2009 | $0.814 | 150.70% |
2010 | $0.966 | 61.90% |
2011 | $0.857 | 41.40% |
2012 | $0.832 | 54.40% |
2013 | $0.793 | 45.30% |
2014 | $0.732 | 28.90% |
2015 | $0.732 | 32.70% |
2016 | $0.570 | 25.20% |
2017 | $0.576 | 14.20% |
2018 | $0.495 | 6.05% |
2019 | $0.0722 | 0.71% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.111 | 1.500 | -2.22 | -3.33 | [0 - 0.5] |
returnOnAssetsTTM | -0.0367 | 1.200 | -1.224 | -1.469 | [0 - 0.3] |
returnOnEquityTTM | -0.0731 | 1.500 | -1.923 | -2.88 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.944 | 0.800 | 5.28 | 4.22 | [1 - 3] |
quickRatioTTM | 1.740 | 0.800 | 4.47 | 3.58 | [0.8 - 2.5] |
cashRatioTTM | 1.100 | 1.500 | 5.00 | 7.50 | [0.2 - 2] |
debtRatioTTM | 0.272 | -1.500 | 5.46 | -8.19 | [0 - 0.6] |
interestCoverageTTM | -6.79 | 1.000 | -3.63 | -3.63 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.192 | 2.00 | 9.94 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -1.029 | 2.00 | -0.514 | -1.029 | [0 - 20] |
debtEquityRatioTTM | 0.559 | -1.500 | 7.76 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.226 | 1.000 | 9.57 | 9.57 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0826 | 1.000 | -3.65 | -3.65 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0542 | 1.000 | -0.810 | -0.810 | [0.2 - 2] |
assetTurnoverTTM | 0.330 | 0.800 | -1.130 | -0.904 | [0.5 - 2] |
Total Score | 3.29 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -10.26 | 1.000 | -1.137 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0731 | 2.50 | -1.236 | -2.88 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.029 | 2.00 | -0.343 | -1.029 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.192 | 2.00 | 9.94 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.494 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0447 | 1.000 | -1.383 | 0 | [0.1 - 0.5] |
Total Score | -0.630 |
Eaton Vance Ohio
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं